Antiemetics and Antinauseants Global Market Report 2022 - ResearchAndMarkets.com
Retrieved on:
Monday, April 11, 2022
Health, Pharmaceutical, Dopamine, Vomiting, Company, Cannabinoid, CW, WHO, Sale, Government, Growth, Dizziness, Benzodiazepine, Pregnancy, Nanoparticle, Gastroenteritis, Food and Drug Administration, Guideline, Incidence, Cancer, Health, Bristol Myers Squibb, Nausea, CINV, Sanofi, Prevalence, Administration, GlaxoSmithKline, SRS, Motion sickness, Nanotechnology, Johnson & Johnson, Steroid, Society, Abbott Laboratories, US Foods, Eli Lilly and Company, Brain, Center, Centers for Disease Control and Prevention, Infection, Awareness, Medical Center, American Society of Clinical Oncology, Eisai, Patient, Merck, Dolasetron, Medical device, Pharmaceutical industry, Ranitidine, Food, Antiemetic, Pfizer
The "Antiemetics And Antinauseants Global Market Report 2022, Drug, Application, End Users" report has been added to ResearchAndMarkets.com's offering.
Key Points:
- The "Antiemetics And Antinauseants Global Market Report 2022, Drug, Application, End Users" report has been added to ResearchAndMarkets.com's offering.
- The antiemetics and antinauseants market consists of sale of antiemetic and antinauseant drugs and related services.
- North America was the largest region in the drugs for antiemetics and antinauseants market in 2021.
- Global Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion